ClearLax

Quick links to important sections

ClearLax

Selected form

Method of action: Laxative

Treatment option: Constipation

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of ClearLax

Quick Facts: ClearLax (Macrogol 3350)

Property Description
Active ingredient Macrogol 3350 (Polyethylene Glycol)
Form Powder for oral solution
Pharmacological class Osmotic laxative
General purpose To increase stool water content and ease passage
Origin Synthetic polymer

What is ClearLax? Defining its Pharmacological Class

ClearLax is a proprietary gastrointestinal agent classified as an Osmotic laxative, primarily used to support the body’s normal bowel function. The active component, Polyethylene Glycol 3350, is a standard agent in this category. This classification confirms that the medicine works by physical means, rather than chemically stimulating the intestinal nerves, a mechanism preferred for daily comfort.

As an Osmotic laxative, ClearLax utilizes an inert mechanism that distinguishes it from stimulant laxatives. Its mode of action focuses on normalizing stool consistency, making this Over-The-Counter (OTC) preparation a recognized option for maintaining predictable bowel movements.

Composition and Form: The Active Role of Macrogol 3350

The core component in ClearLax is the active ingredient Macrogol 3350, which is the non-proprietary chemical name for a high molecular weight Polyethylene Glycol (PEG). Macrogol 3350 is a highly defined synthetic polymer that is minimally absorbed within the body.

The medicine is marketed specifically as a tasteless, single-ingredient powder for oral solution intended for oral administration after being fully dissolved in liquid. Macrogol 3350 is a non-metabolizable and non-absorbable polymer. This finding demonstrates that the active substance works only within the bowel lumen, without affecting other bodily systems.

What is the General Purpose of ClearLax?

The general purpose of ClearLax is to resolve difficulty in passing stool by leveraging the physiological principle of osmosis. The Macrogol 3350 molecule draws water into the colon and prevents its reabsorption. This process results in an increase in stool water content. Consequently, the medicine aids in producing a softer, bulkier stool mass, which facilitates comfortable and natural movement through the gastrointestinal tract.

Regulatory References

  1. Polyethylene Glycol (Macrogol) in NIH DailyMed
  2. Polyethylene Glycol - StatPearls - NCBI Bookshelf

What side effects are possible with ClearLax?

Possible Side Effects and Safety Information for ClearLax

ClearLax (Polyethylene Glycol 3350) is an osmotic laxative generally associated with a favorable safety profile, though it carries specific restrictions and potential adverse reactions based on regulatory documentation.

Adverse Reactions

The majority of side effects are gastrointestinal and typically mild, often resolving with dose reduction or discontinuation. These include bloating, flatulence (gas), nausea, abdominal cramping/pain, and loose, watery, or more frequent stools.

Serious or Clinically Significant Adverse Reactions

Immediate medical attention is necessary if signs of a severe allergic reaction occur (e.g., hives, difficulty breathing, swelling of the face, tongue, or throat). Other serious concerns include rectal bleeding or blood in stools, or diarrhea that is severe, persistent, or accompanied by weakness, dizziness, or fever.

Safety Considerations and Limitations

Category Safety-Related Information (Regulatory Basis)
Contraindications Do not use if allergic to polyethylene glycol, or if known or suspected to have a bowel obstruction or intestinal blockage.
Use Restrictions Use for no more than 7 days unless directed by a health care professional. Prolonged use carries risks of laxative dependence, dehydration, and electrolyte imbalance.
High-Risk Populations Patients with kidney disease should only use under the advice and supervision of a doctor. Safety and effectiveness have not been established for children under 17 years of age.
Drug Interactions Do not combine with starch-based thickeners used for difficulty swallowing, as this may present a risk of choking.

Connection to the Overall Safety Profile

The official safety information highlights that while ClearLax is generally well-tolerated with common mild gastrointestinal effects, its non-absorbable nature requires caution regarding fluid and electrolyte status, especially with extended use. The profile dictates strict limitations on the duration of use and mandates immediate consultation for signs of serious conditions, such as allergic reactions or gastrointestinal bleeding, ensuring that patient use is confined to occasional, short-term relief.

Overdose and Emergency Response

ClearLax Overdose and When to Seek Help

Official regulatory documentation describes overdose of Macrogol 3350 (ClearLax) resulting from taking more than the recommended amount. The most common presentation involves severe gastrointestinal manifestations due to excessive osmotic action.

Documented Manifestations and Severe Outcomes

Overdose may present with extensive diarrhea, abdominal pain, and severe abdominal distension. The primary physiological complication is significant dehydration resulting from fluid loss, which can lead to profound electrolyte disturbances within the body. The most serious outcomes associated with these severe imbalances include neurological events such as seizure, confusion, or the loss of consciousness (inability to be awakened).

Regulatory information notes that special attention must be given to patients, such as the elderly or those with impaired renal or hepatic function, who are more susceptible to complications from fluid imbalance.

Mandated Emergency Actions and Management

Individuals who have taken more than the recommended dosage must consult a doctor or poison control center immediately. Immediate emergency services must be called if the individual shows signs of a life-threatening situation, including collapse, seizure, or trouble breathing.

The officially described management is strictly symptomatic and supportive, focusing on clinical procedures like the correction of electrolyte disturbances, as no specific antidote is known for Macrogol 3350 overdose.

Therapeutic Uses of ClearLax

What ClearLax Treats: Main Uses and Benefits

ClearLax (polyethylene glycol 3350) is an osmotic agent used to address various forms of constipation. Its main use is providing relief for symptoms of occasional constipation. The medicine is commonly utilized to ease irregular bowel movements, manage hard stools, and support the return to a regular bowel pattern. It is also sometimes used under medical guidance in preparation for certain diagnostic procedures.


Quick Fact: Provides Relief for Occasional Constipation

Eligibility and Restrictions for Use

Official Eligibility for ClearLax (Macrogol 3350)

Eligibility for ClearLax is defined by regulatory bodies based on age, existing conditions, and physiological status.


Populations Permitted or Restricted

Population Group Regulatory Status Notes on Restriction
Adults and Older Adolescents Generally permitted Approved for OTC use in adults and children 17 years and older (US label).
Children 16 years and under Restricted use Not approved for OTC use; use must be under the advice of a doctor.
Pregnancy/Lactation Permitted with caution Use is generally allowed due to negligible systemic absorption, but professional consultation is required.
Renal Impairment Conditional use US label advises against use with kidney disease except under medical supervision; international labels note no dosage adjustment for chronic use.

Absolute Contraindications

ClearLax must not be used if a patient has any of the following serious conditions, as stated in official labeling:

  • Known allergy to polyethylene glycol (Macrogol 3350).
  • Intestinal obstruction (bowel blockage) or ileus.
  • Bowel perforation or high risk of perforation.
  • Severe inflammatory conditions like toxic colitis or toxic megacolon.

Consultation with a healthcare provider is also required if experiencing acute symptoms like nausea, vomiting, or abdominal pain, or if using starch-based food thickeners.

What should I know about interactions with other medicines?

ClearLax Interactions with other medicines and products

ClearLax (Polyethylene Glycol 3350) is generally considered to have a low potential for systemic drug interactions because it is minimally absorbed. However, its osmotic action can significantly affect the gastrointestinal tract and the absorption of other orally administered products.

Interactions with Laxatives and Gastrointestinal Agents

Co-administration with other laxatives, stool softeners, or products that commonly cause diarrhea, such as Trofinetide or Tenapanor, is associated with a severe interaction risk. This combination can dramatically increase the incidence and severity of diarrhea and may lead to serious dehydration or electrolyte imbalance. Official guidelines recommend patients stop using other laxatives before initiating certain diarrhea-inducing therapies.

Interactions Affecting Absorption and Safety

  • Diuretics: Concurrent use with diuretics (water pills), such as loop or thiazide-type diuretics, may increase the risk of fluid loss and dehydration. Close monitoring of hydration status and electrolytes is important in this population.
  • Oral Medications: ClearLax may decrease the absorption of other oral medicines, including some antibiotics and other essential drugs, due to the increased speed of transit through the gut.
  • Starch-based Thickeners: Mixing ClearLax powder with starch-based food or liquid thickeners is not generally recommended, as the laxative may counteract the thickening effect, potentially increasing the risk of aspiration in patients with swallowing difficulties.

Mechanism of Action

Physical Mechanism: The Role of Inert Osmotic Action

The action of ClearLax (Macrogol 3350) is fundamentally physical and does not involve the binding or activation of any biological receptors, enzymes, or nerve pathways. The molecule acts strictly as an inert solute within the gastrointestinal lumen. This mechanism involves the formation of hydrogen bonds with water molecules, establishing a powerful hyperosmotic pressure gradient across the colonic wall. This physical interaction defines the mechanism, distinguishing it from processes that rely on chemical stimulation of intestinal activity.

The Cascade: Modulating Transepithelial Fluid Dynamics

The sustained osmotic pressure actively modulates transepithelial water flux by preventing the normal physiological reabsorption of water from the stool mass back into the body. This continuous retention of water directly increases the hydration and volume of the stool, supporting the material's reduction in viscosity. The resulting increase in fecal bulk provides the mechanical stimulus that indirectly leads to peristaltic contractions of the colon smooth muscle. This complete cascade links the molecular action of water retention to the resulting change in colonic fluid dynamics and secondary motility.

Dosage and Administration Information

How to Use ClearLax: Administration Guidelines

ClearLax (Macrogol 3350), as an osmotic laxative powder, has specific usage and administration protocols. Adherence to these guidelines is necessary for proper administration.

Usage Requirement Protocol Details
Route of Administration Strictly oral administration after complete dissolution.
Standard Adult Dosing 17 grams once daily for adults 17 years and older, or 1 to 3 sachets daily as part of a standard dose range.
Preparation The powder must be fully dissolved in 4 to 8 ounces (approx. 120-240 mL) of a suitable beverage (water, juice, tea, coffee, or soda). Do not consume if clumps remain.
Dosing Frequency Typically used once a day. Dosing may be split into divided doses and adjusted according to individual response.
Duration Limits Use for occasional constipation should not exceed 7 days or normally exceed 2 weeks unless otherwise advised by a healthcare provider.

Special Population Administration Rules

Standard labeling addresses specific population groups to maintain consistent use:

  • Pediatric Use: Administration to children 16 years of age or under requires consultation with a medical professional. Adult formulations are not recommended for children below 12 years.
  • Renal Impairment: No dosage change is necessary for the treatment of constipation in patients with renal insufficiency.
  • Administration Constraints: The powder must not be combined with starch-based thickeners as this counteracts the thickening agent's action.

This instruction set defines the standardized approach to using Macrogol 3350 powder, focusing on the route, required preparation, dosing, and duration limits.

Recent Clinical Evidence

Research Evidence / Overview of Studies


How the Drug May Work

Research has investigated the drug’s intended biological effect.

The drug, which is a combination of Drug A (a non-steroidal anti-inflammatory drug or NSAID) and Drug B (an H1-receptor antagonist), has been the subject of several clinical and non-clinical trials.


Summary of Key Research Findings

Effectiveness in Pain and Inflammation

Clinical trials compared the combined treatment to Drug A administered alone in studies evaluating the reduction of inflammation and pain.

Studies investigated whether the drug was associated with a reduction in pain. The biological action of the drug was noted in research investigating the drug’s potential as an analgesic.

  • Acute Pain Management: Several studies focused on its role in acute pain, such as post-operative pain or dental pain. These trials generally compared the combination drug to placebo or to Drug A administered alone.
  • Chronic Pain Conditions: A key study showed the combination was evaluated in managing chronic back pain. Trial results reported varying pain scores among participants receiving the combination compared to the control group over a 12-week period.

Safety and Tolerability Profile

Studies have evaluated the short-term use of the drug in adults. Studies focused on documenting all adverse events.

  • Administration: Research documented the administration method used in the trials.
  • Risk Factors: Study protocols documented specific precautions related to potential drowsiness. Studies identified that participants with a history of ulcers may experience a higher risk of adverse events.

Secondary Findings

Research suggests that the drug was also noted in relation to the quality of sleep, which was a secondary finding in certain trials. This association is still being explored and requires further investigation to understand its relevance.

Frequently Asked Questions (FAQ)

Common questions about ClearLax (FAQ)


Q: How quickly does ClearLax usually start working?

According to the official product information, ClearLax is not an instant-relief laxative. It generally produces a bowel movement within 1 to 3 days of starting use. The product is known for its gradual effect, typically taking a few days to work.


Q: Can I mix ClearLax with anything besides water?

Yes, ClearLax is designed to be highly versatile. Official administration guidelines state that the powder must be fully dissolved in 4 to 8 ounces of any beverage. Suitable liquids often include juice, soda, tea, or coffee (hot, cold, or room temperature). Refer to your specific product label for precise mixing instructions.


Q: How often can you safely take ClearLax?

The typical adult use is once a day for the relief of occasional constipation. The product label specifies that only the recommended amount should be taken, and use should not exceed the stated duration unless advised by a healthcare professional.


Q: Does ClearLax cause dependency if used for a long time?

The regulatory safety information warns that prolonged use of laxatives, including this product, carries a risk of laxative dependence and can also lead to electrolyte imbalance. It is generally intended for short-term use. Any use exceeding the recommended duration should be supervised by a healthcare professional.


Q: What are the most common side effects of ClearLax?

The most commonly reported side effects, according to official labeling, are mild gastrointestinal issues. These can include feelings of nausea, bloating, flatulence (gas), and abdominal cramping or pain.


Q: Can ClearLax interact with anti-depressant medication?

ClearLax may potentially decrease the absorption of other oral medications, including certain prescription drugs, due to the increased speed of transit through the gut. The label advises that patients taking any prescription medication, including antidepressants, consult a doctor or pharmacist before use.


Q: What kind of medical conditions prevent someone from using ClearLax?

The official contraindications state that ClearLax must not be used if a patient is allergic to polyethylene glycol or has a known or suspected bowel obstruction (intestinal blockage). Use for patients with kidney disease requires the advice and supervision of a doctor.


Q: Why does the packaging say to use it for no more than 7 days?

The official over-the-counter label specifies a limit of 7 days because using the product for longer than this period carries risks. These risks include the potential for laxative dependence, dehydration, and electrolyte imbalance. Use beyond this timeframe is not recommended without supervision from a healthcare professional.


Q: Is ClearLax safe for pregnant or breastfeeding women to use?

Due to its minimal systemic absorption, ClearLax may be considered. However, regulatory guidance advises patients who are pregnant or breastfeeding to consult a health professional before using the product.


Q: Is there a generic version of ClearLax that is the same thing?

The active ingredient in ClearLax is Polyethylene Glycol 3350 (also called Macrogol 3350). Since this is the generic name for the substance, many other brands and generic products contain only this identical active ingredient.


Q: Does ClearLax cause stomach cramping?

Yes, according to the product's official safety information, abdominal cramping or pain is listed as a possible side effect of ClearLax.


Q: Can ClearLax be taken on an empty stomach?

The administration instructions define the liquid and preparation required but do not specify whether the product must be taken with or without food. If there are concerns about timing the dose relative to meals, consulting with a healthcare provider is recommended.


Q: Does drinking more water help ClearLax work better?

ClearLax works by drawing water into the stool, making adequate fluid intake essential for its function. Official warnings emphasize maintaining proper hydration to support the product's function and prevent dehydration.


Q: What are the signs that ClearLax is working correctly?

The main sign that ClearLax is working is the relief of occasional constipation (irregularity), which is the product's intended effect. This generally involves the softening of the stool mass and achieving a bowel movement, typically within the expected 1 to 3 days.


Q: Can I take ClearLax if I'm already taking ibuprofen?

ClearLax may decrease the absorption of other oral medications taken at the same time. Patients taking any regular medication are advised on the product label to consult a pharmacist before use.


Q: Does ClearLax have an expiration date I need to watch out for?

Yes, like all medications, the ClearLax powder is assigned an expiration date by the manufacturer. This date reflects the period during which the product is guaranteed to maintain its stability and potency when stored correctly.


Q: Does ClearLax have any sugar or artificial sweeteners in it?

The single-ingredient powder formulation of ClearLax typically contains no inactive ingredients, meaning it contains no sugar or artificial sweeteners. Patients should always check the list of inactive ingredients on their specific product label if using a flavored version.


Q: Is it normal to have some gas when first starting ClearLax?

Yes, flatulence (gas) is explicitly listed in the official adverse reactions information as a common side effect of using the product. This effect is often temporary, especially when first starting use.


Q: What is the maximum duration I can use ClearLax without a break?

The maximum duration of use stated on the over-the-counter label is 7 days. The product is indicated for short-term relief of occasional constipation, and continued use beyond one week requires medical guidance.


Q: Does ClearLax work to prevent constipation or only treat it?

ClearLax is officially indicated for the relief of occasional constipation (irregularity). This means its primary purpose is the treatment of an existing condition.


Q: Can ClearLax interfere with birth control pills?

Similar to other oral medications, ClearLax may decrease the absorption of oral contraceptives (birth control pills). This potential interference is due to increased speed of transit through the gut. Patients taking oral contraceptives are advised to consult a healthcare professional regarding timing due to this potential for reduced absorption.


Q: Is ClearLax gluten-free and safe for someone with celiac disease?

The single-ingredient powder formulation is generally marketed as Gluten Free because it contains no inactive ingredients derived from gluten sources. It is always recommended to verify the inactive ingredients list on the specific package to ensure it meets dietary needs.


Q: Can ClearLax cause nausea?

Yes, nausea is listed in the official adverse reactions information as a common side effect of ClearLax.


Q: Are there any known food interactions with ClearLax?

The most critical interaction related to food is the official precaution to not combine the powder with starch-based thickeners. This combination may counteract the thickening agent, which could pose a risk to individuals with swallowing difficulties.


Q: Is ClearLax habit-forming like some other laxatives?

The product label contains a specific warning that prolonged use of this product, like other laxatives, carries the risk of laxative dependence.


Q: Can ClearLax be used for occasional constipation?

Yes, the indication for use stated on the product label is specifically the relief of occasional constipation (irregularity).


Q: Can I take ClearLax with my morning coffee?

Yes. The administration instructions for ClearLax state that the powder can be mixed with various beverages, including coffee (cold, hot, or room temperature), as long as the powder is completely dissolved.


Q: What are the signs of an allergic reaction to ClearLax?

Signs of a serious allergic reaction, which require immediate medical attention, include hives, rash, itching, swelling of the face, tongue, or throat, or difficulty breathing. If any of these occur, use should be discontinued immediately.


Q: Does ClearLax help with hard, dry stools?

Yes. ClearLax works by drawing water into the colon, a mechanism that increases stool water content. This process helps to produce a softer, bulkier stool mass, which facilitates easier passage.

How should ClearLax be stored and disposed of?

How to Store and Dispose of ClearLax (Polyethylene Glycol 3350)

Official regulatory information mandates specific conditions to maintain the stability and safety of ClearLax.

Storage Requirements

Condition Requirement
Temperature Store at controlled room temperature, 20 C to 25 C (68 F to 77 F).
Handling Keep from freezing, excessive heat, and moisture.
Packaging Preserve in the original tight container, kept tightly closed. Do not use if the tamper-evident seal is missing or broken.
Child Safety Keep out of reach of children.

️ Disposal Instructions

Dispose of outdated or unused medicine properly. Official labeling instructs users to ask a healthcare professional or pharmacist how to dispose of medicine no longer needed, rather than discarding it in household trash or wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of ClearLax found in:

A-Z Index: